Elisa López‐Fernández

Author

Hospital Universitario Virgen de las Nieves

Also Known As

E. Lopez-Fernandez, E. López-Fernández, Elisa Lopez-Fernandez, Elisa Lopez-Fernández, Elisa López-Fernández, Elisa López‐Fernández, López-Fernández, Elisa

Publications

466

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen de las Nieves Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research Universidad de Granada Complejo Hospitalario Universitario de Granada Hospital Clínico Universitario de Valencia

About

Elisa López‐Fernández is an author at Hospital Universitario Virgen de las Nieves specializing in medicine, immunology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	272
2	Engineering	1	1	93
3	Public Health	1	1	42
4	Biomedical Engineering	1	1	93
5	Cellular Therapies	1	1	93

Elisa López‐Fernández

Publications

456

Citations

H-Index

Page 1

	Year	Citations
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study Manuel Jurado, Claudia De La Mata, A. Ruiz‐García, Cytotherapy Regenerative MedicineTissue EngineeringCell TherapyTransplantationEngineering	2017	93
Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis Juan Sáinz, Laila Hassan, Eva García Pérez, Immunology Letters Pulmonary PathologyGenetic EpidemiologyImmunologyInvasive Pulmonary AspergillosisRisk Factor	2007	80
TNFR1 mRNA Expression Level and TNFR1 Gene Polymorphisms are Predictive Markers for Susceptibility to Develop Invasive Pulmonary Aspergillosis Juan Sáinz, I. Salas-Alvarado, Elisa López‐Fernández, International Journal of Immunopathology and Pharmacology	2010	56
Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium Carmen B. Lupiañez, L Canet, Agostinho Carvalho, Infection and Immunity Susceptible HostImmunodeficienciesGenetic EpidemiologyImmunologyHuman Polymorphism	2015	42
Early mortality in multiple myeloma: the time‐dependent impact of comorbidity: A population‐based study in 621 real‐life patients Rafael Ríos, Juan Sáinz, Joaquín Martínez‐López, American Journal of Hematology	2016	39
Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium José Manuel Sánchez‐Maldonado, Ana Moñiz-Díez, Rob ter Horst, Journal of Fungi	2020	36
Trends in survival of multiple myeloma: A thirty-year population-based study in a single institution Rafael Ríos, María‐José Sánchez, José Manuel Puerta, Cancer Epidemiology Hematological MalignancyEpidemiologyMedicineEpidemiology Of CancerHematology	2015	29
Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients Juan Sáinz, E. Pérez, S. Gómez-Lopera, Cytokine InflammationGenetic VariantsInflammatory Lung DiseaseHematologyImmunology	2008	28
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease Paloma García-Martín, Carolina Alarcón-Payer, Elisa López‐Fernández, Annals of Pharmacotherapy	2015	23
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders Mi Kwon, Rebeca Bailén, Pascual Balsalobre, AIDS	2019	20

Page 1